Extracorporeal circulation systems in coronary artery bypass surgery can affect pharmacokinetics of drugs: may altered CYP-mediated liver function be a possible reason?-Reference-Cited by-同舟云学术

Extracorporeal circulation systems in coronary artery bypass surgery can affect pharmacokinetics of drugs: may altered CYP-mediated liver function be a possible reason?

Published:2018-05-09 Issue:8 Volume:74 Page:1095-1095
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Yasar Umit^ORCID,Babaoglu Melih O.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s00228-018-2475-8/fulltext.html

Reference7 articles.

1. Kokki H, Maaroos M, Ellam S, Halonen J, Ojanpera I, Ranta M, Ranta VP, Tolonen A, Lindberg O, Viitala M, Hartikainen J (2018) How do different extracorporeal circulation systems affect metoprolol bioavailability in coronary artery bypass surgery patients. Eur J Clin Pharmacol

2. Valtola A, Kokki H, Gergov M, Ojanpera I, Ranta VP, Hakala T (2007) Does coronary artery bypass surgery affect metoprolol bioavailability. Eur J Clin Pharmacol 63:471–478

3. Frank D, Jaehde U, Fuhr U (2007) Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping. Eur J Clin Pharmacol 63:321–333

4. Goryachkina K, Burbello A, Boldueva S, Babak S, Bergman U, Bertilsson L (2008) CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction. Eur J Clin Pharmacol 64:1163–1173

5. Babaoglu MO, Yasar U, Yorgancioglu C, Ozyuksel A, Akbulut B, Bozkurt A (2007) Effect of the cardiopulmonary bypass procedure during cardiac surgery on CYP2C9 activity in human. FASEB J 21:A1185–A1185